Colloquium to Assess Ten Years of Chickenpox Vaccination
Submitted by Sabin on
Updates
Sabin Receives $150,000 Grant to Strategize for Introduction and Sustainable Use of Vaccines in Developing Countries
Submitted by Sabin on
WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.
Sabin
Seventh Sabin Vaccine Institute Colloquium on Cancer Vaccines and Immunotherapy
Submitted by Sabin on
NEW CANAAN, CT—Thirty-five leading cancer vaccine researchers met to consider medical progress in treating cancer with vaccines during a three-day meeting convened by New Canaan’s Sabin Vaccine Institute (Sabin) held this past June.
Sabin
Sabin Vaccine Institute Honors Scientific Innovators and Newsmaker at Annual Benefit
Submitted by Sabin on
MedImmune, Inc.
Sabin Vaccine Institute Honors Scientific Innovators and Newsmaker at Annual Benefit
Submitted by Sabin on
NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.
Sabin
Sabin Vaccine Institute Receives $21.8 Million Grant to Advance Anti-Hookworm Vaccine
Submitted by Sabin on
Vaccine Developer Albert Z. Kapikian, MD, Awarded the Sabin Gold Medal
Submitted by Sabin on
NEW CANAAN, CT— Albert Z. Kapikian, MD, physician, medical pioneer and viral diseases researcher, received the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.
Sabin
Vaccination: An Act of Love – Now and for the Future
Submitted by Sabin on
Recent outbreaks of a deadly diarrheal disease in Central America have galvanized national leaders, doctors, nurses and parents, as they battle against the killer disease known as rotavirus. Though it affects rich and poor children alike, the disease causes most of its devastation in developing countries, where rotavirus strikes mainly infants and young children; each year approximately 500,000 children around the world die from the disease.
Sabin
FDA Clears Human Hookworm Vaccine for Phase I Safety Trials
Submitted by Sabin on
Sabin/GW Researchers Receive Word on Investigational New Drug Status for Vaccine